Find articles about the foundation, medical trials and other pertinent information.
FOX 8 Cleveland - Rush Inn Bar & Grill of Avon teams up with the Prayers From Maria Foundation on National Childhood Cancer Awareness Day and donates 20 percent of the day's sales to much needed childhood glioma research.
The third annual Sunflower Wine Festival moved to a new venue, the Old River Shops in Rocky River. An amazing collaboration, the event drew thousands of guests and cross-pollinated their reasons for coming. The event is a fundraiser for Prayers From Maria, an organization that funds research into brain tumors that affect children.
Read the full story here.
Old Detroit Road in Rocky River is serving as host to the annual fundraising event, the Sunflower Wine Festival, Saturday from 4pm to midnight, to raise money for the Prayers From Maria Children's Glioma Cancer Foundation.
There is a local effort in the fight to end an often deadly childhood disease -- glioma, a type of brain tumor found in children.
The Prayers From Maria Foundation will hold the Sunflower Wine Festival in Rocky River to raise money for research. To see the complete story, click on the news link.
The foundation becomes a member of the Benacerraf Society for their generous donation of $100,000 and above to support to Dr. Mark Kieran's research at the Dana-Farber Cancer Institute.
Dr. Mark Kieran from Dana-Farber Cancer Institute talks about a new national study to help with treatment for DIPG, the most fatal and deadly form of pediatric brain tumors.
FOX8 News put together a wonderful piece highlighting the foundation, our mission, how we got started, and the impact our grants are making in the research community. It also covered our involvement in the Cleveand Rite Aid Marathon and Rich Figer's story of why he is running and how he is supporting the foundation.
Dr. Mark Kieran, director of the Brain Tumor Program at Dana-Farber/Children's Hospital Cancer Center, has launched a clinical trial that takes advantage of the last 40 years' worth of advances in neurosurgery and in our understanding of biology of cancer to personalize DIPG treatment.
Doctors say the rarity of DIPG tumors and the location in the brain make it hard to advance the science. To wit, there is little funding for research around the country.
An international research team led by the Research Institute of the McGill University Health Centre (RI MUHC) has made a major genetic breakthrough that could change the way pediatric cancers are treated in the future. The researchers identified two genetic mutations responsible for up to 40 per cent of glioblastomas in children - a fatal cancer of the brain that is unresponsive to chemo and radiotherapy treatment. The mutations were found to be involved in DNA regulation, which could explain the resistance to traditional treatments, and may have significant implications on the treatment of other cancers.